Pharmaceutical Medicine

Acknowledgement to Referees

Medicinal Products and Environmental Pollution

Noel Snell

The Importance of Assessing Drug Exposure and Medication Adherence in Evaluating Investigational Medications: Ensuring Validity and Reliability of Clinical Trial Results

Bernard Vrijens, Antoine Pironet, Eric Tousset

“Regulatory Sandboxes” Could Solve the Regulatory Problems Encountered in Europe and Arising from Innovation in Biological Medicinal Products

Mathieu Guerriaud

Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management

Anadil Javaid, Catherine Bennett, Aparna Rao, Lavinia Spain

A Review of the Current FDA-Approved Antibody-Drug Conjugates: Landmark Clinical Trials and Indications

Meghana Kesireddy, Srikanth Reddy Kothapalli, Sai Giridhar Gundepalli, Samia Asif

Eliciting Exploratory Patient Preference Data: A Case Study in a Rare Disease

Kerrie-Anne Ho, Anna Pierce, Meredin Stoltenberg, Thais Tarancon, Carol Mansfield

Evaluation of Physician Knowledge of Safety and Safe Use Information for Intravitreal Aflibercept Injection in Europe: A Second Survey of Physicians Following Dissemination of Updated Risk-Minimization Materials

Laurie J. Zografos, Elizabeth Andrews, Dan L. Wolin, Brian Calingaert, Eric K. Davenport, Alexander Michel, Margarete Latocha, Ursula Maria Schmidt-Ott, Nejra Lovic, Lynne R. Brunck, Kristian T. Johnson, Kiliana Suzart-Woischnik